什么时候考虑目标内微剂量:基于生理学的药理动力学建模方法,以定量确定观察目标参与的关键因素
Yasunori Aoki1,2, Malcom Rowland3, Yuichi Sugiyama1,4
1Laboratory of Quantitative System Pharmacokinetics/Pharmacodynamics, Josai International University, Tokyo, Japan.
Frontiers in pharmacology
|August 9, 2024
概括
目标内微剂量 (ITM) 可以与治疗剂量类似地吸引药物点,但成功率在10mg以上下降. 关键因素包括药物特性和目标组织特征,以有效的早期药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 目标内微剂量 (ITM) 是一种0期临床研究方法.
- 药物开发技术 (ITM) 跨越了临床前和临床药物开发阶段.
- 简化早期药物开发至关重要.
研究的目的:
- 检查影响ITM在目标参与中的有效性因素.
- 评估ITM在治疗剂量水平上攻击目标的能力.
- 确定成功ITM的关键决定因素.
主要方法:
- 基于生理学上的药理动力学 (PBPK) 建模.
- 蒙特卡洛的模拟.
- 对药物和标组织特性进行分析.
主要成果:
- ITM可以实现与某些化合物的全身治疗剂量相比的目标参与.
- 当预测的治疗剂量超过10毫克时,成功的概率会下降.
- 较低的分离常数,较高的全身清除率和最佳的受体丰度提高了ITM的成功.
结论:
- 具有低血流和高药物清除的目标组织有利于ITM.
- 药物特定的药理动力学/药理动力学特性对于ITM适用性至关重要.
- 必须考虑目标组织生理学,才能有效地应用ITM.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
52
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
52
Pharmacokinetic Models: Overview
629
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
629
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
36
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
36
Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
Physiological Pharmacokinetic Models: Assumption with Protein Binding
38
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
38


